News
Researchers have found in a new study that a significant association between psoriasis severity and apical periodontitis (AP) ...
15d
Clinical Trials Arena on MSNJ&J reports analysis from Phase III trial of plaque psoriasis treatmentJ&J has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating plaque psoriasis (PsO).
Dovobet ® is a compounded combination of calcipotriol [also calcipotriene] and betamethasone diproprionate, and is used for psoriasis vulgaris once daily. For this photo case presentation ...
Hosted on MSN3mon
Biocon stock zooms 9% on Psoriasis drug approval from Japan, Jefferies rating upgradeis approved for the treatment of Psoriasis Vulgaris and Psoriatic Arthritis (PsA). Biocon Biologics Ltd previously notified the stock exchanges on August 29, 2024, that the company had entered ...
for enhanced therapeutic effects like acne or psoriasis management. For instance, in October 2023, Canada's Bausch Health Companies Inc. received FDA approval for their acne vulgaris treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results